SNS-595 and methods of using the same

Details for Australian Patent Application No. 2005222622 (hide)

Owner Sunesis Pharmaceuticals, Inc. Dainippon Sumitomo Pharma Co., Ltd.

Inventors Silverman, Jeffrey A.; Higashi, Masaru; Adelman, Daniel C.; Nakao, Satoshi

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005222622

PCT Pub. Number WO2005/089757

Priority 60/553,578 15.03.04 US

Filing date 14 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 7 April 2011

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/089757 Priority application(s): WO2005/089757

7 April 2011 Application Accepted

  Published as AU-B-2005222622

16 June 2011 Application for Amendment

  The nature of the amendment is: Amend the name of the inventor to read Higashi, Masaru and Nakao, Satoshi. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000

6 October 2011 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Higashi, Masaru and Nakao, Satoshi

13 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005222626-A method for inhibiting cancer cell proliferation or increasing cancer cell apoptosis

2005222618-Nanoliter array loading